FindTrial
Sign In

Application of Transcutaneous Electrical Acupoint Stimulation Combined with Dexmedetomidine in the Treatment of Sleep Disorders

Application of Transcutaneous Electrical Acupoint Stimulation Combined with Dexmedetomidine in the Treatment of Sleep Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000561
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyssomnia

Interventions

Positive medicine:Positive medicine
TEAS and Dexmedetomidine:TEAS and Dexmedetomidine
TEAS:TEAS
Dexmedetomidine:Dexmedetomidine

Sponsors

Xuzhou TCM Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1)14 and 95 years old 2) meeting the diagnostic criteria for sleep disorders 3) without severe heart kidney liver and other organ diseases.

Exclusion criteria

Exclusion criteria: 1) Used TEAS or acupuncture within one month; 2) Patients allergic to dexmedetomidine or TEAS. 3) Pregnant or breastfeeding women; 4) Patients with severe cognitive impairment; 5) Patients with drug dependence; 6) Patients with severe neuropsychiatric abnormalities; 7) Severe sleep apnea.

Design outcomes

Primary

MeasureTime frame
sleep quality;HRV;—

Secondary

MeasureTime frame
Dynamic blood sugar;Hospital Anxiety and Depression Scale;blood;NRS scores;Dynamic blood pressure;SF-36;—

Countries

China

Contacts

Public ContactLU Feifei

Xuzhou TCM Hospital

lufei09flg@126.com18795425961

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026